Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
4D Molecular Therapeutics
Biotech
4DMT gets closer to lifting FDA hold on Fabry disease program
4DMT has offered to add an immunosuppressive regimen to a Fabry disease gene therapy in hopes of lifting an FDA clinical hold placed on the program.
Annalee Armstrong
Oct 30, 2023 12:29pm
Madrigal snags Sanofi exec as CEO—Chutes & Ladders
Sep 15, 2023 9:30am
Astellas to test out 4DMT's eye disease gene therapy vector
Jul 10, 2023 7:30pm
FDA slaps hold on 4DMT's phase 1/2 gene therapy trial
Feb 3, 2023 1:28pm
4D's Fabry gene therapy flounders amid adverse events
Jan 11, 2023 10:15am
Roche ditches rights to 4DMT's phase 1 blinding disease therapy
Jun 24, 2021 4:10pm